Currently holds a position at Zosano Pharma Corp
Position | Company | Period |
---|---|---|
Chief Executive Officer, Director | Zosano Pharma Corp | Oct. 21, 2019 - |
Chief Commercial Officer | Puma Biotechnology Inc | Sept. 1, 2015 - Oct. 18, 2019 |
Senior Vice President, Oncology | Corcept Therapeutics Inc | Feb. 1, 2015 - Sept. 4, 2015 |
Senior Vice President, Chief Commercial Officer | Corcept Therapeutics Inc | Nov. 19, 2013 - Feb. 1, 2015 |
Vice President - Commercial Operations | Corcept Therapeutics Inc | Sept. 16, 2010 - Nov. 19, 2013 |
Search
Notification date | Transaction date | B/S Transaction type |
Nb. shares Price Value |
Number of shares | Price | Total value | Details | |
---|---|---|---|---|---|---|---|---|
2022-06-07 | 2022-06-06 |
Zosano Pharma Corp
(ZSAN)
|
S Sale |
442
-3.2%
0.71314 USD |
442 -3.2% | 0.71 | 314 USD | |
2022-04-01 | 2022-03-31 |
Zosano Pharma Corp
(ZSAN)
|
S Sale |
23,633
-4.9%
0.214,965 USD |
23,633 -4.9% | 0.21 | 4,965 USD | |
2019-07-24 | 2019-07-22 |
Puma Biotechnology Inc
(PBYI)
|
PS Planned sale |
1,852
-8.7%
10.0418,600 USD |
1,852 -8.7% | 10.04 | 18,600 USD | |
2019-01-24 | 2019-01-22 |
Puma Biotechnology Inc
(PBYI)
|
PS Planned sale |
2,114
-9.0%
24.9152,664 USD |
2,114 -9.0% | 24.91 | 52,664 USD | |
2018-07-24 | 2018-07-20 |
Puma Biotechnology Inc
(PBYI)
|
PS Planned sale |
1,839
-7.3%
51.8595,360 USD |
1,839 -7.3% | 51.85 | 95,360 USD | |
2018-01-24 | 2018-01-22 |
Puma Biotechnology Inc
(PBYI)
|
PS Planned sale |
1,858
-6.8%
92.85172,515 USD |
1,858 -6.8% | 92.85 | 172,515 USD | |
2017-07-24 | 2017-07-20 |
Puma Biotechnology Inc
(PBYI)
|
PS Planned sale |
1,990
-6.8%
94.90188,853 USD |
1,990 -6.8% | 94.90 | 188,853 USD | |
2017-01-24 | 2017-01-20 |
Puma Biotechnology Inc
(PBYI)
|
PS Planned sale |
2,290
-7.3%
33.2476,108 USD |
2,290 -7.3% | 33.24 | 76,108 USD |